
    
      This is a 16-week, randomized, double-blind, multicenter study comparing the effect of
      naproxcinod, naproxen, and ibuprofen on 24 hour arterial blood pressure profile. Patients
      will be randomly allocated to naproxcinod 375mg, naproxcinod 750mg, naproxen 250mg, naproxen
      500mg, or ibuprofen 600mg in a 1:1:1:1:1 ratio.
    
  